Mrs K H, aged 64 History: The patient presented in August 1972 with a six-week history of painless obstructive jaundice. Itching of the skin had been present intermittently for eight years and had become generalized and of increasing severity for three years. Pigmentation of the skin had been noticed for one year. There had been a short episode of severe xerostomia three years previously and dryness and reddening of the eyes had been noticed for three weeks.
On examination: She was jaundiced, and there was a marked, generalized, melanotic pigmentation which in places was reminiscent of intense freckling. Several spider nevi and superficial telangiectasia not of the Osler-Weber-Rendu type were present over the face and anterior chest. The skin, particularly of the hands, arms, neck and face, was strikingly thickened. There was atrophy of the finger pulps but no Raynaud's phenomenon. The liver and spleen were enlarged.
Investigations: Bilirubin 4.4 mg/100 ml; alkaline phosphatase 500 iu/l.; SGOT 240 iu/l.; prothrombin time normal; cholesterol 275 mg/100 ml; total protein 7.4 g/100 ml (albumin 3.0 g/100 ml). Immunoglobulins: polyclonal gammopathy with IgM showing the greatest proportional increase. ESR 50 mm in one hour (Westergren). Mitochondrial antibody: immunofluorescence positive; ANF positive 1:640, smooth muscle antibody positive. Australia antigen negative. Barium swallow: no varices but abnormal peristalsis of the cesophagus. Liver biopsy: compatible with primary biliary cirrhosis (PBC). Tear secretion reduced (Schirmer's test). X-ray of hands: terminal phalanges eroded; no soft tissue calcification. Skin biopsy: compatible with scleroderma.
Treatment and progress: Cholestyramine 4 g per day. Calcium and vitamins A and D supplements. International PBC azathioprine trial (azathioprine v. placebo). She remains well; the jaundice, pruritus and pigmentation have lessened and the skin appears less thickened.
Discussion
Three chronic liver syndromes are regularly associated with autoantibodies in the serum -primary biliary cirrhosis, active chronic (lupoid) hepatitis and cryptogenic cirrhosis. This suggests that altered immunity may be important in their etiology. The incidence of multisystem involvement in these three diseases supports this suggestion.
Liver disease found in association with scleroderma was described by Milbradt in 1934. However, it was not until Reynolds et al. (1971) drew attention to 6 cases of PBC with features of the CRST syndrome (calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia) that the association became generally appreciated. The CRST syndrome is a benign variant of systemic sclerosis though a few patients have evidence of systemic involvement usually manifest as a disturbance of cesophageal motility. The telangiectasia of this syndrome is very similar to that seen in hereditary haemorrhagic telangiectasiathe Osler-Weber-Rendu syndrome. Three further cases of PBC with features of the CRST syndrome have been described, 2 by Murray-Lyon et al. (1970) and one by Diaz & Schuman (1972) .
O'Brien et al. (1972) described the first case in which PBC and scleroderma, without features of the CRST syndrome, were associated. This patient is similar but had the additional feature of keratoconjunctivitis sicca. Although the number of these cases reported remains small the association of PBC and systemic sclerosis is probably more than coincidental and suggests that these two diseases might have a common autoimmune basis.
